We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABM icon
1926
ABM Industries
ABM
$2.83B
$94K ﹤0.01%
2,099
+1,655
+373% +$76.5K
ENOV icon
1927
Enovis
ENOV
$1.42B
$94K ﹤0.01%
1,769
+262
+17% +$15.2K
FHI icon
1928
Federated Hermes
FHI
$4.7B
$94K ﹤0.01%
2,340
-50
-2% -$1.96K
GSBC icon
1929
Great Southern Bancorp
GSBC
$875M
$94K ﹤0.01%
1,850
-3,082
-62% -$175K
PCVX icon
1930
Vaxcyte
PCVX
$8.81B
$94K ﹤0.01%
2,497
+1,755
+237% +$74.4K
PD icon
1931
PagerDuty
PD
$915M
$94K ﹤0.01%
2,673
+2,251
+533% +$66.1K
PLL
1932
DELISTED
Piedmont Lithium
PLL
$94K ﹤0.01%
1,569
+1,357
+640% +$82.3K
RNST icon
1933
Renasant Corp
RNST
$3.92B
$94K ﹤0.01%
3,064
+2,725
+804% +$95.3K
VONE icon
1934
Vanguard Russell 1000 ETF
VONE
$8.65B
$94K ﹤0.01%
+505
New +$92K
WLK icon
1935
Westlake Corp
WLK
$10.3B
$94K ﹤0.01%
808
-156
-16% -$18K
ALTR
1936
DELISTED
Altair Engineering Inc
ALTR
$94K ﹤0.01%
1,301
-3,330
-72% -$197K
AM icon
1937
Antero Midstream
AM
$10.5B
$93K ﹤0.01%
8,846
+829
+10% +$8.82K
CMBM
1938
DELISTED
Cambium Networks
CMBM
$93K ﹤0.01%
5,263
+5,181
+6,318% +$105K
EBS icon
1939
Emergent Biosolutions
EBS
$228M
$93K ﹤0.01%
8,949
-5,467
-38% -$66.1K
ING icon
1940
ING
ING
$101B
$93K ﹤0.01%
7,824
+7,823
+782,300% +$104K
OABI icon
1941
OmniAb
OABI
$491M
$93K ﹤0.01%
25,256
-2,060
-8% -$7.78K
AMSC icon
1942
American Superconductor
AMSC
$1.56B
$92K ﹤0.01%
18,812
+10,841
+136% +$54.5K
DNLI icon
1943
Denali Therapeutics
DNLI
$3.95B
$92K ﹤0.01%
4,005
+2,451
+158% +$67.5K
SMPL icon
1944
Simply Good Foods
SMPL
$961M
$92K ﹤0.01%
2,315
-1,808
-44% -$66.8K
TSLS icon
1945
Direxion Daily TSLA Bear 1X ETF
TSLS
$75.5M
$92K ﹤0.01%
354
+350
+8,750% +$119K
JBTM
1946
JBT Marel
JBTM
$6.32B
$92K ﹤0.01%
845
-1,512
-64% -$160K
ACI icon
1947
Albertsons Companies
ACI
$5.95B
$91K ﹤0.01%
4,386
+931
+27% +$19.2K
ACLS icon
1948
Axcelis
ACLS
$4.18B
$91K ﹤0.01%
680
-3,479
-84% -$409K
ALIT icon
1949
Alight
ALIT
$364M
$91K ﹤0.01%
495
-88
-15% -$16.2K
EFOR
1950
Everforth Inc
EFOR
$1.35B
$91K ﹤0.01%
1,100
-1,414
-56% -$123K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.